Table 4.
Organs in which benzo(a)pyrene significantly (at least two doses) and dose-dependently increased tumor incidence (number of tumor-bearing animals/number of total animals is presented).
| Study | Species, sex | BaP dose | Daily intake (mg/kg bw per day) | Forestomach | Liver | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diet (ppm) | Gavage (mg/kg bw per day) | Papillomas and/or carcinomas | Papillomas | Carcinomas | Adenomas and/or carcinomas | Adenomas | Carcinomas | |||
| Culp et al. (1998) | Female mice | 0 | 0* | 1/48 | ||||||
| 5 | 0.65* | 3/47 | ||||||||
| 25 | 3.5* | 36/46‡ | ||||||||
| 100 | 15.2* | 46/47‡ | ||||||||
| Wester et al. (2012) | Male rats | 0 | 0§ | 0/52 | 0/52 | 0/52 | 0/52 | 0/52 | 0/52 | |
| 3 | 2.14§ | 8/52‡ | 7/52‡ | 1/52 | 4/52 | 3/52 | 1/52 | |||
| 10 | 7.14§ | 43/52‡ | 18/52‡ | 25/52‡ | 38/52‡ | 15/52‡ | 23/52‡ | |||
| 30 | 21.43§ | 52/52‡ | 17/52‡ | 35/52‡ | 49/52‡ | 4/52 | 45/52‡ | |||
| Female rats | 0 | 0§ | 1/52 | 1/52 | 0/52 | 0/52 | 0/52 | 0/52 | ||
| 3 | 2.14§ | 6/51 | 3/51 | 3/51 | 2/52 | 2/52 | 0/52 | |||
| 10 | 7.14§ | 30/51‡ | 20/51‡ | 10/51‡ | 39/52‡ | 7/52‡ | 32/52‡ | |||
| 30 | 21.43§ | 50/52‡ | 25/52‡ | 25/52‡ | 51/52‡ | 1/52 | 50/52‡ | |||
Calculated daily intake, corrected for food consumption (Cal/EPA (2010) calculation based on food consumption and body weight).
† Reported by Schneider et al. (2002).
Significantly different from control (p < 0.05) as reported in Benford et al. (2010) or in Cal/EPA (2010).
Administered dose of 5 days per week was adjusted to 7 days per week daily dose (dose × 5/7).